Calm down when the heart is stressed: Inhibiting calmodulin-dependent protein kinase II for antiarrhythmias

van Oort, 2014, CaMKII confirms its promise in ischaemic heart disease, Eur J Heart Fail, 16, 1268, 10.1002/ejhf.204 Grandi, 2014, CaMKII comes of age in cardiac health and disease, Front Pharmacol, 5, 154, 10.3389/fphar.2014.00154 Bers, 2011, Ca2+-calmodulin-dependent protein kinase II regulation of cardiac excitation– transcription coupling, Heart Rhythm, 8, 1101, 10.1016/j.hrthm.2011.01.030 Couchonnal, 2008, The role of calmodulin kinase II in myocardial physiology and disease, Physiology (Bethesda), 23, 151, 10.1152/physiol.00043.2007 Westenbrink, 2015, Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation, Circ Res, 10.1161/CIRCRESAHA.116.304682 Ziolo, 2015, Defining the role of oxidative stress in atrial fibrillation and diabetes, J Cardiovasc Electrophysiol, 26, 223, 10.1111/jce.12560 Fischer, 2014, Ca(2+)/calmodulin-dependent protein kinase II equally induces sarcoplasmic reticulum Ca(2+) leak in human ischaemic and dilated cardiomyopathy, Eur J Heart Fail, 16, 1292, 10.1002/ejhf.163 Mitsuyama, 2014, Ca2+/calmodulin-dependent protein kinase II increases the susceptibility to the arrhythmogenic action potential alternans in spontaneously hypertensive rats, Am J Physiol Heart Circ Physiol, 307, H199, 10.1152/ajpheart.00387.2012 Bell, 2014, CaMKII-dependent responses to ischemia and reperfusion challenges in the heart, Front Pharmacol, 5, 96, 10.3389/fphar.2014.00096 Luczak, 2014, CaMKII oxidative activation and the pathogenesis of cardiac disease, J Mol Cell Cardiol, 73, 112, 10.1016/j.yjmcc.2014.02.004 Sossalla, 2010, Inhibition of elevated Ca2+/calmodulin-dependent protein kinase II improves contractility in human failing myocardium, Circ Res, 107, 1150, 10.1161/CIRCRESAHA.110.220418 Grimm, 2011, Crossing signals: relationships between β-adrenergic stimulation and CaMKII activation, Heart Rhythm, 8, 1296, 10.1016/j.hrthm.2011.02.027 Zhao, 2011, Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling, J Mol Cell Cardiol, 50, 128, 10.1016/j.yjmcc.2010.11.001 Zhao, 2015, Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart, Am J Physiol Heart Circ Physiol, 308, H240, 10.1152/ajpheart.00630.2014 Zhang, 2005, Calmodulin kinase II inhibition protects against structural heart disease, Nat Med, 11, 409, 10.1038/nm1215 Belardinelli, 2015, Cardiac late Na(+) current: Proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress, Heart Rhythm, 12, 440, 10.1016/j.hrthm.2014.11.009 Bers, 2009, Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels, J Cardiovasc Pharmacol, 54, 180, 10.1097/FJC.0b013e3181a25078 Erickson, 2011, CaMKII in the cardiovascular system: sensing redox states, Physiol Rev, 91, 889, 10.1152/physrev.00018.2010 Maier, 2011, CaMKII regulation of voltage-gated sodium channels and cell excitability, Heart Rhythm, 8, 474, 10.1016/j.hrthm.2010.09.080 Purohit, 2013, Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation, Circulation, 128, 1748, 10.1161/CIRCULATIONAHA.113.003313 Swaminathan, 2011, Oxidized CaMKII causes cardiac sinus node dysfunction in mice, J Clin Invest, 121, 3277, 10.1172/JCI57833 Wu, 2014, CaMKII in sinoatrial node physiology and dysfunction, Front Pharmacol, 5, 48, 10.3389/fphar.2014.00048 Xie, 2009, Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling, Circ Res, 104, 79, 10.1161/CIRCRESAHA.108.183475 Nagy, 2011, Role of Ca(2)+-sensitive K+ currents in controlling ventricular repolarization: possible implications for future antiarrhytmic drug therapy, Curr Med Chem, 18, 3622, 10.2174/092986711796642463 Hund, 2014, Role of CaMKII in cardiac arrhythmias, Trends Cardiovasc Med Banyasz, 2011, Cardiac calmodulin kinase: a potential target for drug design, Curr Med Chem, 18, 3707, 10.2174/092986711796642409 Pellicena, 2014, CaMKII inhibitors: from research tools to therapeutic agents, Front Pharmacol, 5, 21, 10.3389/fphar.2014.00021 Erickson, 2014, Mechanisms of CaMKII activation in the heart, Front Pharmacol, 5, 59, 10.3389/fphar.2014.00059 Gray, 2014, CaMKIIdelta subtypes: localization and function, Front Pharmacol, 5, 15, 10.3389/fphar.2014.00015 Duan, 2014, Pharmacophenomics: a new paradigm for pharmacology, toxicology, and personalized medicine, Chin J Pharmacol Toxicol, 28, 1